Clinical Trials Logo

Recurrent Nonsmall Cell Lung Cancer clinical trials

View clinical trials related to Recurrent Nonsmall Cell Lung Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT03004105 Withdrawn - Clinical trials for Advanced Lung Cancer

MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)

Start date: May 2018
Phase: Phase 2
Study type: Interventional

The goal of this clinical research study is to learn if MEDI4736 given in combination with selumetinib can help to control advanced lung cancer. The safety of this drug combination will also be studied.